Who
Brendan M. O'Malley
SVP, Chief Legal Officer
Company insider
Files Form 4 as: SVP, Chief Legal Officer, Abeona Therapeutics.
In numbers
- Trades disclosed
- 42
- Buys
- 4
- Sells
- 14
- Bought
- $88K
- Sold
- $791K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 20 Sep 2021
- Last trade
- 29 Sep 2026
- Last filed
- 29 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Sep 2026filed 29 Sep 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $35K6,727 at $5.16 | filing |
| 29 Sep 2026filed 29 Sep 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $35K6,727 at $5.16 | filing |
| 9 Jul 2026filed 9 Jul 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $84K12,050 at $6.96 | filing |
| 9 Jul 2026filed 9 Jul 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $84K12,050 at $6.96 | filing |
| 9 Jun 2026filed 9 Jun 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $33K6,305 at $5.30 | filing |
| 9 Jun 2026filed 9 Jun 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $33K6,305 at $5.30 | filing |
| 8 Jun 2026filed 9 Jun 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $26K4,826 at $5.43 | filing |
| 8 Jun 2026filed 9 Jun 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $26K4,826 at $5.43 | filing |
| 22 Jan 2026filed 22 Jan 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $72K13,578 at $5.33 | filing |
| 22 Jan 2026filed 22 Jan 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $72K13,578 at $5.33 | filing |
| 20 Jan 2026filed 20 Jan 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —113,949 at $0.00 | filing |
| 20 Jan 2026filed 20 Jan 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —113,949 at $0.00 | filing |
| 29 Sep 2025filed 1 Oct 2025 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $50K9,366 at $5.39 | filing |
| 22 Sep 2025filed 22 Sep 2025 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $3,736688 at $5.43 | filing |
| 9 Jul 2025filed 10 Jul 2025 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $102K17,428 at $5.86 | filing |
| 6 Jun 2025filed 6 Jun 2025 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $71K10,470 at $6.76 | filing |
| 3 Mar 2025filed 4 Mar 2025 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code F | $948181 at $5.24 | filing |
| 21 Jan 2025filed 23 Jan 2025 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —115,607 at $0.00 | filing |
| 28 Sep 2024filed 30 Sep 2024 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code F | $39K6,579 at $5.89 | filing |
| 20 Sep 2024filed 24 Sep 2024 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code F | $2,986496 at $6.02 | filing |
News
No headline names them, or the companies they trade most, lately.